Indaptus Therapeutics, Inc. (INDP)
NASDAQ: INDP · Real-Time Price · USD
1.000
-0.070 (-6.54%)
At close: Aug 17, 2026, 4:00 PM EDT
1.000
0.00 (0.00%)
Pre-market: Aug 18, 2026, 7:03 AM EDT
Indaptus Therapeutics Market Cap
Indaptus Therapeutics has a market cap or net worth of $113.24 million as of August 18, 2026. Its market cap has increased by 1,337.38% in one year.
Market Cap
113.24M
Enterprise Value
101.69M
1-Year Change
1,337.38%
Ranking
Category
Stock Price
$1.00
ChartMarket Cap Chart
Since August 4, 2021, Indaptus Therapeutics's market cap has increased from $47.95M to $113.24M, an increase of 136.16%. That is a compound annual growth rate of 18.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 113.24M | 2,122.23% |
| Dec 31, 2025 | 5.10M | -49.63% |
| Dec 31, 2024 | 10.12M | -31.58% |
| Dec 29, 2023 | 14.79M | 21.38% |
| Dec 30, 2022 | 12.18M | -73.92% |
| Dec 31, 2021 | 46.70M | -2.60% |
| Aug 4, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ProMIS Neurosciences | 133.26M |
| Polaryx Therapeutics | 129.60M |
| Genelux | 121.68M |
| Vivani Medical | 120.73M |
| Inovio Pharmaceuticals | 119.51M |
| Yarrow Bioscience | 118.97M |
| Black Diamond Therapeutics | 116.06M |
| Seer, Inc. | 115.06M |